Emma Frye Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill Guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
Linda Callahan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 751 Loveland Miamiville Rd, Loveland, OH 45140 Phone: 513-575-0190 |
Lauren Long Ferris, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill-guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
Kaitlyn Jean Kish Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill-guinea Pike,, Loveland, OH 45140 Phone: 513-791-1458 |
Alora Rose Contant Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 757 S Lebanon Rd, Loveland, OH 45140 Phone: 513-774-7000 |
Elizabeth Transue, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1398 Teal Ct, Loveland, OH 45140 Phone: 614-246-1829 |
David Negrelli Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2411 Arrowhead Trl, Loveland, OH 45140 Phone: 330-715-4467 |
Claire Jordan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9370 Union Cemetery Rd, Loveland, OH 45140 Phone: 513-677-4900 |
Maryellen M Zinnecker, MA,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12095 Stone Point Ct, Loveland, OH 45140 Phone: 513-702-3101 Fax: 513-672-0704 |
Miss Hali Zorb, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill Guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
Mrs. Susan Mechler, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 S Lebanon Rd, Loveland, OH 45140 Phone: 513-796-3609 |
Mrs. Kathleen Nora Meade, MA. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11820 Enyart Rd, Loveland, OH 45140 Phone: 513-686-1740 Fax: 513-677-7861 |
Tammy Geer, MCD CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5735 Clemens Dr, Loveland, OH 45140 Phone: 901-848-5643 |
Brooke Leo, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill-guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
Mrs. Danielle Simmons Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill Guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
Jennifer Carroll Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1120 Cottonwood Dr, Loveland, OH 45140 Phone: 513-967-4942 |
Ms. Sarah G Cousino, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Loveland Madeira Rd, Loveland, OH 45140 Phone: 513-697-3057 |
Katie Georges Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11821 Hawthorn Woods Ct, Loveland, OH 45140 Phone: 513-831-9690 |
Julia Scherler, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill Guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
Mrs. Gillian Carter Evans, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6642 Branch Hill Guinea Pike, Loveland, OH 45140 Phone: 513-791-1458 |
News Archive
Neos Therapeutics, Inc., a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that Adzenys XR-ODT™ is in distribution channels and is now available to prescribe for patients with ADHD in the United States.
3D-printable resins, such as those used in dental applications, are marketed as biocompatible. Clear tooth aligners, a multi-billion-dollar industry, use these resins. Many other consumer products use 3D-printable resins.
The 21st century is shaping up to be the "century of vaccines," as vaccine developers make striking progress against both emerging and longstanding diseases, according to Vaccines: Preventing Diseases and Protecting Health, from the Pan American Health Organization (PAHO).
FibroGen, Inc. today announced results from a Phase 2 open-label study of FG-3019, an investigational anti-fibrotic antibody, in combination with gemcitabine and erlotinib for the treatment of patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
Rituals such as those centered around holidays and other celebrations play an important part in human relationships.
› Verified 9 days ago